Marcos da imunização ativa
da história aos avanços na pandemia covid-19
DOI:
https://doi.org/10.61695/rcs.v2i3.50Keywords:
Active Immunization, Vaccination, COVID-19Abstract
With the discovery by Edward Janner and the advancement of vaccination, several diseases have been controlled, with recent emphasis on COVID-19, which was responsible for the pandemic that occurred from 2020 to 2023 and resulted in the fastest development of vaccines of all time, breaking the previous record of five years to just one. This research aims to provide a historical overview of the active immunization process by vaccination and demonstrate the importance of COVID-19 vaccination and the types of vaccines to reduce and debunk misinformation surrounding this topic. The study was conducted through an integrative literature review. The PubMed database and academic books were used for the literature search. This review presents the discovery of the principle of immunization, the main controlled and eradicated diseases, the classes of vaccines, the development and types of vaccines against SARS-CoV-2, and the observed effects of these vaccines in clinical trials. This research elucidates the progression of active immunization through vaccination, tracing its trajectory from Edward Jenner's discovery to the zenith epitomized by the rapid development of COVID-19 vaccines. The study underscores the historical significance of immunization and accentuates the scientific prowess in addressing emergent challenges, such as the global pandemic. As evidenced in this inquiry, the advancement of vaccines reaffirms the pertinence of immunization in advancing public health.
Downloads
References
Margotta R. História ilustrada da medicina. 1ª ed. Barueri: Manole; 1994.
Rezende JM. Varíola: uma Doença Extinta. In: À sombra do plátano: crônicas de história da medicina [Internet]. São Paulo: Editora Unifesp; 2009. p. 227-230. Série História da Medicina, vol. 2. ISBN 978-85-61673-63-5. Disponível em: https://doi.org/10.7476/9788561673635.0024.
Revista Médica de Minas Gerais (RMMG). História da Medicina: História da Varíola. Disponível em: https://rmmg.org/artigo/detalhes/1461.
Silveira MM, Moreira GMSG, Mendonça M. DNA vaccines against COVID-19: Perspectives and challenges. PubMed; 2020. Disponível em: https://pubmed.ncbi.nlm.nih.gov/33352173/.
Cattel L, et al. Vaccine development and technology for SARS‐CoV‐2: Current insight. PubMed; 2021. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8662109/.
Yadav T, et al. Recombinant vaccines for COVID-19. PubMed; 2020. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711739/#s0003title.
Silveira MM, et al. DNA vaccines against COVID-19: Perspectives and challenges. PubMed; 2020. Disponível em: https://pubmed.ncbi.nlm.nih.gov/33352173/.
Fundação Butantan. Coronavac: o que a ciência comprova. Instituto Butantan; 2023. Disponível em: https://butantan.gov.br/src/pluguins/2023/janeiro/livro_coronavac_janeiro/book/#page/1.
Yadav T, et al. Recombinant vaccines for COVID-19. PubMed; 2020. Disponível em: https://pubmed.ncbi.nlm.nih.gov/33232211/.
Brüssow H. COVID-19: vaccination problems. PubMed; 2021. Disponível em: https://pubmed.ncbi.nlm.nih.gov/33928745/.
Li M, et al. COVID-19 vaccine development: milestones, lessons and prospects. PubMed; 2021. Disponível em: https://pubmed.ncbi.nlm.nih.gov/35504917.
Meo SA, et al. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines. PubMed; 2021. Disponível em: https://pubmed.ncbi.nlm.nih.gov/33629336/.
Iba T, Levy JH. Thrombosis and thrombocytopenia in COVID-19 and after COVID-19 vaccination. PubMed; 2021. Disponível em: https://pubmed.ncbi.nlm.nih.gov/35202800/.
Quais são as diferenças entre as vacinas contra Covid-19 que estão sendo aplicadas no Brasil? Disponível em: : https://butantan.gov.br/covid/butantan-tira-duvida/tira-duvida-noticias/quais-sao-as-diferencas-entre-as-vacinas-contra-covid-19-que-estao-sendo-aplicadas-no-brasil.
Forchette L, et al. A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics. PubMed; 2021. Disponível em: https://pubmed.ncbi.nlm.nih.gov/34241776/.
Chen Y, et al. New-onset autoimmune phenomena post-COVID-19 vaccination. PubMed; 2021. Disponível em: https://pubmed.ncbi.nlm.nih.gov/34957554/.
Bok K, et al. Accelerated COVID-19 vaccine development: milestones, lessons, and prospects. PubMed; 2021. Disponível em: https://pubmed.ncbi.nlm.nih.gov/34348117/.
Fiolet T, et al. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review. PubMed; 2021. Disponível em: https://pubmed.ncbi.nlm.nih.gov/34715347/.
Khan WH, et al. COVID-19 Pandemic and Vaccines Update on Challenges and Resolutions. PubMed; 2021. Disponível em: https://pubmed.ncbi.nlm.nih.gov/34568087/.
Fang E, et al. Advances in COVID-19 mRNA vaccine development. PubMed; 2021. Disponível em: https://pubmed.ncbi.nlm.nih.gov/35322018/.
Campos ALV de, Nascimento DR do, Maranhão E. A história da poliomielite no Brasil e seu controle por imunização. História, Ciências, Saúde-Manguinhos. 2003;10.
Bandyopadhyay AS, et al. Polio vaccination: past, present and future. Future microbiology. 2015;10(5):791–808.
Kayser V, Ramzan I. Vaccines and vaccination: history and emerging issues. Human vaccines & immunotherapeutics. 2021;17(12):5255–5268.
Conis E. Measles and the modern history of vaccination. Public health reports (Washington, D.C.: 1974). 2019;134(2):118–125.
Roitt IM, Delves PJ. Fundamentos de imunologia. Rio De Janeiro: Guanabara Koogan; 2013.
Coico R, Sunshine G. Imunologia. Rio De Janeiro: Guanabara Koogan; 2010.
Levinson WE. Microbiologia médica e imunologia. Porto Alegre (Rs): Artmed; 2010.
History of polio vaccination. Disponível em: https://www.who.int/news-room/spotlight/history-of-vaccination/history-of-polio-vaccination?topicsurvey=ht7j2q)&gclid=CjwKCAjwzuqgBhAcEiwAdj5dRrVztVo1FC5j8eKaA_YDe-8YtrOna_tXZr5EQVjO_OrDzmgR2Vi9zxoCVMkQAvD_BwE.
History of measles vaccination. Disponível em: https://www.who.int/news-room/spotlight/history-of-vaccination/history-of-measles-vaccination?topicsurvey=ht7j2q)&gclid=CjwKCAjwzuqgBhAcEiwAdj5dRk_0ezmC0--I66MfUAsEKyVKUmML6bzj25gosf9MUoMDvCD6NKEgwRoCj9IQAvD_BwE.
Domingues CMA, et al. A evolução do sarampo no Brasil e a situação atual. Informe Epidemiologico do SUS. 1997;6(1):7–19.
Bayani F, et al. An overview of the vaccine platforms to combat COVID-19 with a focus on the subunit vaccines. ScienceDirect. 18 de março de 2023. Disponível em: https://www.sciencedirect.com/science/article/pii/S0079610723000160.
Organização Mundial da Saúde (OMS). OMS adiciona vacina da Janssen à lista de ferramentas de emergência seguras e eficazes contra COVID-19. Disponível em: https://www.paho.org/pt/noticias/12-3-2021-oms-adiciona-vacina-da-janssen-lista-ferramentas-emergencia-seguras-e-eficazes#:~:text=A%20vacina%20da%20Janssen%20%C3%A9,eficaz%20em%20popula%C3%A7%C3%B5es%20mais%20velhas
Tregoning JS, et al. Vaccines for COVID-19. PubMed; 2020. Disponível em: https://pubmed.ncbi.nlm.nih.gov/32935331/.
Ninomiya VY. Vacinação COVID-19: Janssen (Johnson & Johnson). Disponível em: https://coronavirus.saude.mg.gov.br/blog/331-vacinacao-covid-19-janssen.
Stephenson KE, et al. Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19. PubMed; 2021. Disponível em: https://pubmed.ncbi.nlm.nih.gov/33704352/.
Shkoda AS, et al. Sputnik V Effectiveness against Hospitalization with COVID-19 during Omicron Dominance. PubMed; 2023. Disponível em: https://pubmed.ncbi.nlm.nih.gov/35746546/.
Behera P, et al. Effectiveness of COVID-19 vaccine (Covaxin) against breakthrough SARS-CoV-2 infection in India. PubMed; 2023. Disponível em: https://pubmed.ncbi.nlm.nih.gov/35321625/.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Beatriz Rodrigues Dutra, Layla Luiza Mota Sena, Érico Augusto Rosas de Vasconcelos
This work is licensed under a Creative Commons Attribution 4.0 International License.
